Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.51961309 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.51961309 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.16334196 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.16334196 |
5 | exogenous drug catabolic process (GO:0042738) | 7.12890544 |
6 | epoxygenase P450 pathway (GO:0019373) | 6.88656558 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 6.77498724 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.16521344 |
9 | tryptophan catabolic process (GO:0006569) | 6.13354754 |
10 | indole-containing compound catabolic process (GO:0042436) | 6.13354754 |
11 | indolalkylamine catabolic process (GO:0046218) | 6.13354754 |
12 | kynurenine metabolic process (GO:0070189) | 6.00822239 |
13 | bile acid biosynthetic process (GO:0006699) | 5.90321671 |
14 | omega-hydroxylase P450 pathway (GO:0097267) | 5.85288127 |
15 | tryptophan metabolic process (GO:0006568) | 5.79106871 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.70205271 |
17 | glyoxylate metabolic process (GO:0046487) | 5.69561277 |
18 | urea metabolic process (GO:0019627) | 5.53863626 |
19 | urea cycle (GO:0000050) | 5.53863626 |
20 | cysteine metabolic process (GO:0006534) | 5.37496106 |
21 | negative regulation of fibrinolysis (GO:0051918) | 5.35346341 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.29089612 |
23 | complement activation, alternative pathway (GO:0006957) | 5.20376601 |
24 | protein carboxylation (GO:0018214) | 5.20337606 |
25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.20337606 |
26 | regulation of protein activation cascade (GO:2000257) | 5.19010086 |
27 | sulfur amino acid catabolic process (GO:0000098) | 5.18104026 |
28 | regulation of fibrinolysis (GO:0051917) | 5.15779891 |
29 | nitrogen cycle metabolic process (GO:0071941) | 5.09587206 |
30 | bile acid metabolic process (GO:0008206) | 5.09499425 |
31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.04618148 |
32 | serine family amino acid catabolic process (GO:0009071) | 5.01893661 |
33 | drug metabolic process (GO:0017144) | 5.00638648 |
34 | aromatic amino acid family metabolic process (GO:0009072) | 4.91671388 |
35 | regulation of complement activation (GO:0030449) | 4.85547088 |
36 | homocysteine metabolic process (GO:0050667) | 4.80958081 |
37 | lysine metabolic process (GO:0006553) | 4.72097242 |
38 | lysine catabolic process (GO:0006554) | 4.72097242 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 4.68282808 |
40 | regulation of cholesterol esterification (GO:0010872) | 4.68060453 |
41 | tyrosine metabolic process (GO:0006570) | 4.67567201 |
42 | reverse cholesterol transport (GO:0043691) | 4.66698661 |
43 | amino-acid betaine metabolic process (GO:0006577) | 4.64004208 |
44 | protein-lipid complex remodeling (GO:0034368) | 4.60439057 |
45 | macromolecular complex remodeling (GO:0034367) | 4.60439057 |
46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.60439057 |
47 | alpha-amino acid catabolic process (GO:1901606) | 4.58824818 |
48 | triglyceride homeostasis (GO:0070328) | 4.54745580 |
49 | acylglycerol homeostasis (GO:0055090) | 4.54745580 |
50 | cellular ketone body metabolic process (GO:0046950) | 4.49237232 |
51 | negative regulation of sterol transport (GO:0032372) | 4.49194666 |
52 | negative regulation of cholesterol transport (GO:0032375) | 4.49194666 |
53 | bile acid and bile salt transport (GO:0015721) | 4.47730156 |
54 | regulation of plasminogen activation (GO:0010755) | 4.46559020 |
55 | phospholipid efflux (GO:0033700) | 4.46435940 |
56 | negative regulation of protein activation cascade (GO:2000258) | 4.44105981 |
57 | phenylpropanoid metabolic process (GO:0009698) | 4.40819857 |
58 | indolalkylamine metabolic process (GO:0006586) | 4.36783926 |
59 | oxidative demethylation (GO:0070989) | 4.34977405 |
60 | glycine metabolic process (GO:0006544) | 4.32210664 |
61 | negative regulation of hemostasis (GO:1900047) | 4.31560782 |
62 | negative regulation of blood coagulation (GO:0030195) | 4.31560782 |
63 | coenzyme catabolic process (GO:0009109) | 4.31005933 |
64 | ethanol metabolic process (GO:0006067) | 4.27002954 |
65 | cellular glucuronidation (GO:0052695) | 4.26480242 |
66 | amine catabolic process (GO:0009310) | 4.23937760 |
67 | cellular biogenic amine catabolic process (GO:0042402) | 4.23937760 |
68 | cellular amino acid catabolic process (GO:0009063) | 4.23789755 |
69 | imidazole-containing compound metabolic process (GO:0052803) | 4.23577988 |
70 | glutamate metabolic process (GO:0006536) | 4.22095058 |
71 | plasma lipoprotein particle clearance (GO:0034381) | 4.21801338 |
72 | drug catabolic process (GO:0042737) | 4.16798394 |
73 | serine family amino acid metabolic process (GO:0009069) | 4.15604971 |
74 | cholesterol efflux (GO:0033344) | 4.14876172 |
75 | benzene-containing compound metabolic process (GO:0042537) | 4.11628402 |
76 | plasma lipoprotein particle organization (GO:0071827) | 4.08963969 |
77 | ethanol oxidation (GO:0006069) | 4.06140698 |
78 | cellular modified amino acid catabolic process (GO:0042219) | 4.05980942 |
79 | flavonoid metabolic process (GO:0009812) | 4.01101683 |
80 | intestinal absorption (GO:0050892) | 4.00883470 |
81 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.00428303 |
82 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99135024 |
83 | negative regulation of coagulation (GO:0050819) | 3.98405330 |
84 | polyketide metabolic process (GO:0030638) | 3.95663994 |
85 | doxorubicin metabolic process (GO:0044598) | 3.95663994 |
86 | daunorubicin metabolic process (GO:0044597) | 3.95663994 |
87 | serine family amino acid biosynthetic process (GO:0009070) | 3.95035700 |
88 | plasma lipoprotein particle assembly (GO:0034377) | 3.94837186 |
89 | acute-phase response (GO:0006953) | 3.94396297 |
90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.91308469 |
91 | ketone body metabolic process (GO:1902224) | 3.88642550 |
92 | regulation of bile acid biosynthetic process (GO:0070857) | 3.87866033 |
93 | regulation of humoral immune response (GO:0002920) | 3.86587918 |
94 | negative regulation of wound healing (GO:0061045) | 3.86485127 |
95 | arginine metabolic process (GO:0006525) | 3.82769958 |
96 | aldehyde catabolic process (GO:0046185) | 3.82633198 |
97 | fibrinolysis (GO:0042730) | 3.81641003 |
98 | protein-lipid complex subunit organization (GO:0071825) | 3.81622907 |
99 | regulation of cholesterol homeostasis (GO:2000188) | 3.81447587 |
100 | uronic acid metabolic process (GO:0006063) | 3.80146780 |
101 | glucuronate metabolic process (GO:0019585) | 3.80146780 |
102 | phospholipid homeostasis (GO:0055091) | 3.78589580 |
103 | short-chain fatty acid metabolic process (GO:0046459) | 3.76473893 |
104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76183029 |
105 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.75871431 |
106 | organic acid catabolic process (GO:0016054) | 3.74702254 |
107 | carboxylic acid catabolic process (GO:0046395) | 3.74702254 |
108 | cholesterol homeostasis (GO:0042632) | 3.74476099 |
109 | intestinal cholesterol absorption (GO:0030299) | 3.73521884 |
110 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.71994462 |
111 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.71994462 |
112 | heme transport (GO:0015886) | 3.70750866 |
113 | positive regulation of lipid catabolic process (GO:0050996) | 3.70250634 |
114 | acetyl-CoA metabolic process (GO:0006084) | 3.69723376 |
115 | sterol homeostasis (GO:0055092) | 3.68856174 |
116 | cofactor catabolic process (GO:0051187) | 3.66057373 |
117 | complement activation, classical pathway (GO:0006958) | 3.64957145 |
118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.64856720 |
119 | S-adenosylmethionine metabolic process (GO:0046500) | 3.64116420 |
120 | drug transmembrane transport (GO:0006855) | 3.63320362 |
121 | positive regulation of blood coagulation (GO:0030194) | 3.62227540 |
122 | positive regulation of hemostasis (GO:1900048) | 3.62227540 |
123 | cytolysis (GO:0019835) | 3.60021842 |
124 | complement activation (GO:0006956) | 3.59883228 |
125 | negative regulation of complement activation (GO:0045916) | 3.59743515 |
126 | urate metabolic process (GO:0046415) | 3.58500925 |
127 | protein activation cascade (GO:0072376) | 3.56627975 |
128 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.55894572 |
129 | protein-lipid complex assembly (GO:0065005) | 3.54069752 |
130 | negative regulation of lipase activity (GO:0060192) | 3.53805707 |
131 | lipoprotein metabolic process (GO:0042157) | 3.50884480 |
132 | hormone catabolic process (GO:0042447) | 3.49984968 |
133 | alkaloid metabolic process (GO:0009820) | 3.45467312 |
134 | positive regulation of coagulation (GO:0050820) | 3.38266319 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.30934233 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.15318424 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92403549 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50178203 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.21417016 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00208465 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.57594921 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06074777 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.95095241 |
10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.06886080 |
11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06015730 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7272445 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94804863 |
14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76081459 |
15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66170282 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.63633371 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54815931 |
18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54704591 |
19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45472586 |
20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40605160 |
21 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.37269901 |
22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26639113 |
23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22086980 |
24 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18960422 |
25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17838326 |
26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15845436 |
27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15814103 |
28 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15399059 |
29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.14574732 |
30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12588282 |
31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11927759 |
32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10808338 |
33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09735979 |
34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08396927 |
35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06646622 |
36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05775454 |
37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02293527 |
38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00317866 |
39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97396153 |
40 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.94633149 |
41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94256407 |
42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93894957 |
43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.93883113 |
44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93496992 |
45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92298518 |
46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92120952 |
47 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.90992111 |
48 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90976187 |
49 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89187521 |
50 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88737798 |
51 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.88736486 |
52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88670482 |
53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.87947318 |
54 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.87811514 |
55 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86209485 |
56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83817862 |
57 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.83672703 |
58 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.82863321 |
59 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.82707393 |
60 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.82212479 |
61 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.81723945 |
62 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.81496376 |
63 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.81322288 |
64 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81143035 |
65 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81070980 |
66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80955277 |
67 | STAT3_23295773_ChIP-Seq_U87_Human | 0.79902914 |
68 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.79209385 |
69 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79205148 |
70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79162796 |
71 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78970258 |
72 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.78422922 |
73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78313663 |
74 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.77952516 |
75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.77857245 |
76 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.77109092 |
77 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76996534 |
78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76806185 |
79 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.76570339 |
80 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.76570339 |
81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76505738 |
82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76407124 |
83 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.76294304 |
84 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.76122835 |
85 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75758571 |
86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.75241371 |
87 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.74859080 |
88 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74673612 |
89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74650256 |
90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.74632180 |
91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.74632180 |
92 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.73952430 |
93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.73104219 |
94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72845650 |
95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72681481 |
96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72581704 |
97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68677058 |
98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65823365 |
99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65823365 |
100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64079645 |
101 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63249878 |
102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62849946 |
103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61844549 |
104 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60795691 |
105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59964030 |
106 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59368873 |
107 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59112639 |
108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58476167 |
109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57325864 |
110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56697837 |
111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55556677 |
112 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55279567 |
113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.53389335 |
114 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53121463 |
115 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52908114 |
116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52819134 |
117 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52092725 |
118 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51755361 |
119 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51699404 |
120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.50680250 |
121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50151695 |
122 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.48652552 |
123 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48100510 |
124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.47608593 |
125 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.47479090 |
126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47366741 |
127 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46589761 |
128 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.46524906 |
129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.46283935 |
130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.46051497 |
131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45780176 |
132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45407719 |
133 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44638205 |
134 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.44243779 |
135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43365356 |
136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.43027159 |
137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42945842 |
138 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42395404 |
139 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41725244 |
140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39588017 |
141 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39521716 |
142 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38775934 |
143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.38639272 |
144 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.38389078 |
145 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37612750 |
146 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37463657 |
147 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37197018 |
148 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36167367 |
149 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35880617 |
150 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35770884 |
151 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.35410219 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.23598955 |
2 | MP0005360_urolithiasis | 7.65084576 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.39901794 |
4 | MP0005365_abnormal_bile_salt | 6.25098920 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.04142979 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.18970553 |
7 | MP0003252_abnormal_bile_duct | 4.05152152 |
8 | MP0010329_abnormal_lipoprotein_level | 3.51748122 |
9 | MP0005083_abnormal_biliary_tract | 3.17715285 |
10 | MP0009840_abnormal_foam_cell | 3.10376251 |
11 | MP0003195_calcinosis | 3.00175830 |
12 | MP0001666_abnormal_nutrient_absorption | 2.82611366 |
13 | MP0005332_abnormal_amino_acid | 2.80350537 |
14 | MP0004019_abnormal_vitamin_homeostasis | 2.28384048 |
15 | MP0000609_abnormal_liver_physiology | 2.13692915 |
16 | MP0002138_abnormal_hepatobiliary_system | 2.11951440 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.09164958 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.08936806 |
19 | MP0003868_abnormal_feces_composition | 1.91924876 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.80305342 |
21 | MP0001764_abnormal_homeostasis | 1.64538649 |
22 | MP0009697_abnormal_copulation | 1.53514328 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52359929 |
24 | MP0009780_abnormal_chondrocyte_physiolo | 1.46828790 |
25 | MP0005451_abnormal_body_composition | 1.38406959 |
26 | MP0009643_abnormal_urine_homeostasis | 1.35502431 |
27 | MP0003122_maternal_imprinting | 1.35013835 |
28 | MP0003011_delayed_dark_adaptation | 1.18474235 |
29 | MP0003186_abnormal_redox_activity | 1.17391302 |
30 | MP0000598_abnormal_liver_morphology | 1.14765635 |
31 | MP0002909_abnormal_adrenal_gland | 1.14417090 |
32 | MP0005084_abnormal_gallbladder_morpholo | 1.12732574 |
33 | MP0003656_abnormal_erythrocyte_physiolo | 1.12452181 |
34 | MP0005647_abnormal_sex_gland | 1.05631527 |
35 | MP0005636_abnormal_mineral_homeostasis | 1.05463382 |
36 | MP0003705_abnormal_hypodermis_morpholog | 1.04942706 |
37 | MP0003183_abnormal_peptide_metabolism | 1.00086644 |
38 | MP0000604_amyloidosis | 0.99295889 |
39 | MP0009764_decreased_sensitivity_to | 0.98578284 |
40 | MP0002254_reproductive_system_inflammat | 0.96394259 |
41 | MP0009763_increased_sensitivity_to | 0.95843847 |
42 | MP0005220_abnormal_exocrine_pancreas | 0.93913345 |
43 | MP0000566_synostosis | 0.92450190 |
44 | MP0005408_hypopigmentation | 0.89333939 |
45 | MP0003879_abnormal_hair_cell | 0.89242326 |
46 | MP0009642_abnormal_blood_homeostasis | 0.87989914 |
47 | MP0002078_abnormal_glucose_homeostasis | 0.87442984 |
48 | MP0008469_abnormal_protein_level | 0.86700341 |
49 | MP0005379_endocrine/exocrine_gland_phen | 0.84788088 |
50 | MP0010368_abnormal_lymphatic_system | 0.83850263 |
51 | MP0006036_abnormal_mitochondrial_physio | 0.82312583 |
52 | MP0002876_abnormal_thyroid_physiology | 0.79588854 |
53 | MP0005670_abnormal_white_adipose | 0.78356901 |
54 | MP0009765_abnormal_xenobiotic_induced | 0.76064557 |
55 | MP0005376_homeostasis/metabolism_phenot | 0.75519729 |
56 | MP0001756_abnormal_urination | 0.74645492 |
57 | MP0001915_intracranial_hemorrhage | 0.71427514 |
58 | MP0002971_abnormal_brown_adipose | 0.71349093 |
59 | MP0005334_abnormal_fat_pad | 0.70379161 |
60 | MP0005535_abnormal_body_temperature | 0.69509901 |
61 | MP0001661_extended_life_span | 0.67593604 |
62 | MP0004130_abnormal_muscle_cell | 0.67349821 |
63 | MP0005448_abnormal_energy_balance | 0.63096921 |
64 | MP0005266_abnormal_metabolism | 0.62970100 |
65 | MP0003172_abnormal_lysosome_physiology | 0.61673913 |
66 | MP0002132_abnormal_respiratory_system | 0.60864573 |
67 | MP0002928_abnormal_bile_duct | 0.60585882 |
68 | MP0000013_abnormal_adipose_tissue | 0.60036534 |
69 | MP0000639_abnormal_adrenal_gland | 0.59707229 |
70 | MP0006035_abnormal_mitochondrial_morpho | 0.58168801 |
71 | MP0003329_amyloid_beta_deposits | 0.58000139 |
72 | MP0003690_abnormal_glial_cell | 0.56988767 |
73 | MP0009053_abnormal_anal_canal | 0.56901729 |
74 | MP0005409_darkened_coat_color | 0.55267236 |
75 | MP0002136_abnormal_kidney_physiology | 0.54139016 |
76 | MP0002693_abnormal_pancreas_physiology | 0.53609952 |
77 | MP0002837_dystrophic_cardiac_calcinosis | 0.49469613 |
78 | MP0004147_increased_porphyrin_level | 0.48768031 |
79 | MP0004043_abnormal_pH_regulation | 0.48035334 |
80 | MP0003953_abnormal_hormone_level | 0.47863115 |
81 | MP0003638_abnormal_response/metabolism_ | 0.47737842 |
82 | MP0005646_abnormal_pituitary_gland | 0.47725552 |
83 | MP0002822_catalepsy | 0.47422138 |
84 | MP0005395_other_phenotype | 0.46921929 |
85 | MP0000003_abnormal_adipose_tissue | 0.46347315 |
86 | MP0005464_abnormal_platelet_physiology | 0.45599218 |
87 | MP0005645_abnormal_hypothalamus_physiol | 0.44132465 |
88 | MP0004264_abnormal_extraembryonic_tissu | 0.43935707 |
89 | MP0006054_spinal_hemorrhage | 0.43615755 |
90 | MP0005551_abnormal_eye_electrophysiolog | 0.43602641 |
91 | MP0002089_abnormal_postnatal_growth/wei | 0.42142923 |
92 | MP0004782_abnormal_surfactant_physiolog | 0.41942064 |
93 | MP0003724_increased_susceptibility_to | 0.40773427 |
94 | MP0008874_decreased_physiological_sensi | 0.39386722 |
95 | MP0008873_increased_physiological_sensi | 0.38943303 |
96 | MP0003718_maternal_effect | 0.38652787 |
97 | MP0000230_abnormal_systemic_arterial | 0.38296873 |
98 | MP0001944_abnormal_pancreas_morphology | 0.37403459 |
99 | MP0003633_abnormal_nervous_system | 0.37392340 |
100 | MP0005187_abnormal_penis_morphology | 0.37241516 |
101 | MP0005666_abnormal_adipose_tissue | 0.36901946 |
102 | MP0005164_abnormal_response_to | 0.36294335 |
103 | MP0002168_other_aberrant_phenotype | 0.35300880 |
104 | MP0001765_abnormal_ion_homeostasis | 0.35263111 |
105 | MP0004381_abnormal_hair_follicle | 0.34790907 |
106 | MP0005248_abnormal_Harderian_gland | 0.34738439 |
107 | MP0002796_impaired_skin_barrier | 0.34442775 |
108 | MP0003436_decreased_susceptibility_to | 0.34259652 |
109 | MP0001501_abnormal_sleep_pattern | 0.34184854 |
110 | MP0009672_abnormal_birth_weight | 0.34171702 |
111 | MP0009384_cardiac_valve_regurgitation | 0.33702789 |
112 | MP0005166_decreased_susceptibility_to | 0.33207405 |
113 | MP0008872_abnormal_physiological_respon | 0.33030678 |
114 | MP0003632_abnormal_nervous_system | 0.32877381 |
115 | MP0010234_abnormal_vibrissa_follicle | 0.32830963 |
116 | MP0003943_abnormal_hepatobiliary_system | 0.32547981 |
117 | MP0003959_abnormal_lean_body | 0.31101799 |
118 | MP0003075_altered_response_to | 0.31093066 |
119 | MP0000579_abnormal_nail_morphology | 0.31069556 |
120 | MP0002970_abnormal_white_adipose | 0.30765897 |
121 | MP0009115_abnormal_fat_cell | 0.30667045 |
122 | MP0010386_abnormal_urinary_bladder | 0.30009893 |
123 | MP0003123_paternal_imprinting | 0.29425855 |
124 | MP0000538_abnormal_urinary_bladder | 0.28538582 |
125 | MP0005058_abnormal_lysosome_morphology | 0.28374618 |
126 | MP0006082_CNS_inflammation | 0.28367075 |
127 | MP0005410_abnormal_fertilization | 0.28057543 |
128 | MP0001243_abnormal_dermal_layer | 0.27255002 |
129 | MP0001845_abnormal_inflammatory_respons | 0.27068666 |
130 | MP0001881_abnormal_mammary_gland | 0.26608302 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.30630114 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.26574191 |
3 | Deep venous thrombosis (HP:0002625) | 7.07751466 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.50129501 |
5 | Hypobetalipoproteinemia (HP:0003563) | 6.42149531 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.31168494 |
7 | Xanthomatosis (HP:0000991) | 6.19417003 |
8 | Complement deficiency (HP:0004431) | 5.21203639 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.20557475 |
10 | Hypolipoproteinemia (HP:0010981) | 4.68907401 |
11 | Joint hemorrhage (HP:0005261) | 4.58032513 |
12 | Hyperammonemia (HP:0001987) | 4.55363635 |
13 | Epidermoid cyst (HP:0200040) | 4.53259881 |
14 | Hyperglycinemia (HP:0002154) | 4.48201014 |
15 | Ketosis (HP:0001946) | 4.41165713 |
16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.37092165 |
17 | Fat malabsorption (HP:0002630) | 4.29802837 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.27418169 |
19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.26948566 |
20 | Hypoglycemic coma (HP:0001325) | 4.19241460 |
21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.15476261 |
22 | Conjugated hyperbilirubinemia (HP:0002908) | 4.13784834 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06373965 |
24 | Hyperglycinuria (HP:0003108) | 4.05429558 |
25 | Abnormality of methionine metabolism (HP:0010901) | 4.00981327 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.00681022 |
27 | Abnormality of glycine metabolism (HP:0010895) | 4.00681022 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 3.92979306 |
29 | Abnormality of complement system (HP:0005339) | 3.78164300 |
30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.74665010 |
31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.66459268 |
32 | Hypercholesterolemia (HP:0003124) | 3.61077940 |
33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42135635 |
34 | Ketoacidosis (HP:0001993) | 3.39831044 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39279418 |
36 | Hyperbilirubinemia (HP:0002904) | 3.38553441 |
37 | Nephritis (HP:0000123) | 3.17420720 |
38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.11013608 |
39 | Osteomalacia (HP:0002749) | 3.10835825 |
40 | Steatorrhea (HP:0002570) | 3.09819204 |
41 | Delayed CNS myelination (HP:0002188) | 3.09420930 |
42 | Abnormality of serum amino acid levels (HP:0003112) | 3.00414796 |
43 | Hepatocellular carcinoma (HP:0001402) | 2.90806180 |
44 | Hypoglycemic seizures (HP:0002173) | 2.90171244 |
45 | Myocardial infarction (HP:0001658) | 2.85736952 |
46 | Skin nodule (HP:0200036) | 2.84658362 |
47 | Abnormality of purine metabolism (HP:0004352) | 2.83290777 |
48 | Hypochromic microcytic anemia (HP:0004840) | 2.82171220 |
49 | Metabolic acidosis (HP:0001942) | 2.80894381 |
50 | Acanthocytosis (HP:0001927) | 2.80447683 |
51 | Spontaneous abortion (HP:0005268) | 2.77408912 |
52 | Hyperphosphaturia (HP:0003109) | 2.72185833 |
53 | Gout (HP:0001997) | 2.70746529 |
54 | Systemic lupus erythematosus (HP:0002725) | 2.63480733 |
55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59990952 |
56 | Dicarboxylic aciduria (HP:0003215) | 2.59990952 |
57 | Vascular calcification (HP:0004934) | 2.59584890 |
58 | Lethargy (HP:0001254) | 2.57349687 |
59 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44618102 |
60 | Abnormal gallbladder morphology (HP:0012437) | 2.44187924 |
61 | Malnutrition (HP:0004395) | 2.42839773 |
62 | Late onset (HP:0003584) | 2.41782779 |
63 | Mitral stenosis (HP:0001718) | 2.39842462 |
64 | Irritability (HP:0000737) | 2.38867693 |
65 | Spastic diplegia (HP:0001264) | 2.34880642 |
66 | Cholelithiasis (HP:0001081) | 2.33376834 |
67 | Glomerulonephritis (HP:0000099) | 2.33275960 |
68 | Abnormal urine phosphate concentration (HP:0012599) | 2.31618977 |
69 | Arthropathy (HP:0003040) | 2.31401718 |
70 | Cerebral edema (HP:0002181) | 2.30418992 |
71 | Cardiovascular calcification (HP:0011915) | 2.29094561 |
72 | Potter facies (HP:0002009) | 2.25487767 |
73 | Facial shape deformation (HP:0011334) | 2.25487767 |
74 | Neonatal onset (HP:0003623) | 2.24827436 |
75 | Abnormal gallbladder physiology (HP:0012438) | 2.24770289 |
76 | Cholecystitis (HP:0001082) | 2.24770289 |
77 | Generalized aminoaciduria (HP:0002909) | 2.24237578 |
78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23969586 |
79 | Enlarged kidneys (HP:0000105) | 2.22573976 |
80 | Pancreatitis (HP:0001733) | 2.20419076 |
81 | Sensorimotor neuropathy (HP:0007141) | 2.20194313 |
82 | Esophageal varix (HP:0002040) | 2.19463863 |
83 | Hypothermia (HP:0002045) | 2.17774805 |
84 | Purpura (HP:0000979) | 2.14238217 |
85 | Brushfield spots (HP:0001088) | 2.12938175 |
86 | Poikilocytosis (HP:0004447) | 2.07725390 |
87 | Vomiting (HP:0002013) | 2.07595335 |
88 | Amyloidosis (HP:0011034) | 2.06619077 |
89 | Hyperglycemia (HP:0003074) | 2.06547885 |
90 | Rickets (HP:0002748) | 2.05950432 |
91 | Menorrhagia (HP:0000132) | 2.05201068 |
92 | Symptomatic seizures (HP:0011145) | 2.05179949 |
93 | Opisthotonus (HP:0002179) | 2.02428118 |
94 | Gingival bleeding (HP:0000225) | 2.02043811 |
95 | Abnormality of proline metabolism (HP:0010907) | 1.98526552 |
96 | Hydroxyprolinuria (HP:0003080) | 1.98526552 |
97 | Abnormality of the gallbladder (HP:0005264) | 1.98148488 |
98 | Alkalosis (HP:0001948) | 1.96988023 |
99 | Proximal tubulopathy (HP:0000114) | 1.96731625 |
100 | Joint swelling (HP:0001386) | 1.96403642 |
101 | Fair hair (HP:0002286) | 1.95425185 |
102 | Thrombophlebitis (HP:0004418) | 1.93645059 |
103 | Hemorrhage of the eye (HP:0011885) | 1.93088474 |
104 | Pigmentary retinal degeneration (HP:0001146) | 1.91946447 |
105 | Abnormality of vitamin metabolism (HP:0100508) | 1.91525937 |
106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91297592 |
107 | Abnormality of vitamin B metabolism (HP:0004340) | 1.90787621 |
108 | Abnormality of urine glucose concentration (HP:0011016) | 1.90413659 |
109 | Glycosuria (HP:0003076) | 1.90413659 |
110 | Renal cortical cysts (HP:0000803) | 1.90076223 |
111 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85324423 |
112 | Abnormal tarsal ossification (HP:0008369) | 1.84287824 |
113 | Hypophosphatemic rickets (HP:0004912) | 1.81868570 |
114 | Abnormal cartilage morphology (HP:0002763) | 1.81142278 |
115 | Widely patent fontanelles and sutures (HP:0004492) | 1.79656209 |
116 | Hypophosphatemia (HP:0002148) | 1.73360691 |
117 | Pulmonary embolism (HP:0002204) | 1.71301767 |
118 | Bifid scrotum (HP:0000048) | 1.64343618 |
119 | Retinal atrophy (HP:0001105) | 1.57245689 |
120 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.56557739 |
121 | Mucopolysacchariduria (HP:0008155) | 1.56557739 |
122 | Megaloblastic anemia (HP:0001889) | 1.52911389 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.59911183 |
2 | ERN1 | 4.31495799 |
3 | SIK1 | 4.26431631 |
4 | FGFR4 | 4.25336856 |
5 | INSRR | 3.57822452 |
6 | TAOK3 | 3.52053893 |
7 | ACVR1B | 3.47508835 |
8 | PIK3CG | 2.95811382 |
9 | ERBB4 | 2.73206196 |
10 | MAPK15 | 2.45780749 |
11 | FRK | 2.35857065 |
12 | MST1R | 2.27797821 |
13 | MAP2K4 | 2.07091242 |
14 | PKN2 | 1.97463632 |
15 | FLT3 | 1.91313612 |
16 | STK39 | 1.84506157 |
17 | MAPK11 | 1.83199997 |
18 | NTRK3 | 1.74645119 |
19 | LATS1 | 1.62457068 |
20 | PTK6 | 1.57297894 |
21 | TYK2 | 1.52692842 |
22 | NLK | 1.51428457 |
23 | MAP3K12 | 1.48535367 |
24 | TRIB3 | 1.47519808 |
25 | DAPK2 | 1.47106959 |
26 | WNK3 | 1.45617429 |
27 | FER | 1.43245199 |
28 | NEK9 | 1.32288908 |
29 | MAP4K2 | 1.28006103 |
30 | ABL2 | 1.21071798 |
31 | MAP3K7 | 1.19995579 |
32 | FGFR1 | 1.17691566 |
33 | PRKAA2 | 1.17484434 |
34 | FGFR2 | 1.14173644 |
35 | JAK2 | 1.14012664 |
36 | STK24 | 1.13758269 |
37 | CASK | 1.13117768 |
38 | PRKG2 | 1.12552561 |
39 | MAP3K9 | 1.11284377 |
40 | MAP3K10 | 1.10923290 |
41 | STK38L | 1.08686814 |
42 | KDR | 1.08252917 |
43 | OXSR1 | 1.06675111 |
44 | ERBB2 | 0.98624809 |
45 | PINK1 | 0.98150698 |
46 | GRK6 | 0.97683543 |
47 | DYRK1B | 0.95105192 |
48 | MET | 0.93736164 |
49 | BRSK2 | 0.93053311 |
50 | CAMKK2 | 0.92973785 |
51 | JAK1 | 0.92864923 |
52 | MST4 | 0.92636832 |
53 | TBK1 | 0.91510625 |
54 | MAP3K14 | 0.91283451 |
55 | MAP3K4 | 0.90781907 |
56 | MAP2K3 | 0.85127726 |
57 | PRKCZ | 0.84623825 |
58 | MAPK4 | 0.83004988 |
59 | MAP3K3 | 0.82320799 |
60 | PRKCE | 0.80285211 |
61 | CSK | 0.78504380 |
62 | PHKG1 | 0.78033065 |
63 | PHKG2 | 0.78033065 |
64 | EPHB1 | 0.77132786 |
65 | CAMK1D | 0.74991641 |
66 | MAP3K11 | 0.74880750 |
67 | IRAK3 | 0.74061545 |
68 | PRKAA1 | 0.73274232 |
69 | EPHA3 | 0.73002907 |
70 | WNK4 | 0.72765977 |
71 | RIPK1 | 0.72067179 |
72 | PRKACG | 0.71775270 |
73 | CSNK1E | 0.70418765 |
74 | ADRBK2 | 0.69339761 |
75 | PTK2 | 0.69321045 |
76 | LMTK2 | 0.69243216 |
77 | GSK3A | 0.69147678 |
78 | PRKG1 | 0.69056963 |
79 | CDK6 | 0.67491958 |
80 | WNK1 | 0.65576650 |
81 | SGK3 | 0.65081359 |
82 | PDK2 | 0.64289629 |
83 | YES1 | 0.61420156 |
84 | TIE1 | 0.60575941 |
85 | MAPK12 | 0.60224659 |
86 | RPS6KB1 | 0.60041557 |
87 | MAPKAPK3 | 0.59989952 |
88 | SGK1 | 0.59523417 |
89 | CAMK2G | 0.58698320 |
90 | TRPM7 | 0.58228435 |
91 | MAP2K6 | 0.57966533 |
92 | EIF2AK3 | 0.57254174 |
93 | PRKACA | 0.57171588 |
94 | CAMK2D | 0.56394228 |
95 | CDK12 | 0.55583963 |
96 | BMPR1B | 0.51318622 |
97 | MAPK7 | 0.50213111 |
98 | SGK2 | 0.49407651 |
99 | PDPK1 | 0.48858369 |
100 | CSNK1D | 0.47983606 |
101 | FGFR3 | 0.47701143 |
102 | MAP3K1 | 0.47297025 |
103 | PRKACB | 0.47174997 |
104 | MAP3K2 | 0.44543405 |
105 | PRKCQ | 0.43725068 |
106 | IGF1R | 0.43680945 |
107 | MTOR | 0.43474106 |
108 | MAP2K1 | 0.42023456 |
109 | STK3 | 0.41995308 |
110 | SGK223 | 0.41428304 |
111 | SGK494 | 0.41428304 |
112 | PRKCB | 0.40591738 |
113 | GRK1 | 0.40374441 |
114 | MAP2K2 | 0.39839344 |
115 | IKBKE | 0.39381889 |
116 | CSNK1A1 | 0.39084756 |
117 | TNIK | 0.38956834 |
118 | PAK3 | 0.38849247 |
119 | MAP3K13 | 0.38569605 |
120 | CSF1R | 0.37867448 |
121 | CSNK1G1 | 0.37815475 |
122 | RET | 0.37601391 |
123 | KSR2 | 0.37166541 |
124 | SRC | 0.36708687 |
125 | TGFBR2 | 0.36549967 |
126 | MAP3K5 | 0.36043430 |
127 | EIF2AK1 | 0.34953363 |
128 | MYLK | 0.34249632 |
129 | PRKCG | 0.31334138 |
130 | ICK | 0.30236223 |
131 | PDK1 | 0.28990539 |
132 | CAMK1G | 0.28609135 |
133 | AKT3 | 0.28471512 |
134 | PDK3 | 0.28404583 |
135 | PDK4 | 0.28404583 |
136 | IRAK1 | 0.28005299 |
137 | PIK3CA | 0.27577344 |
138 | CDK4 | 0.27420464 |
139 | PRKCA | 0.26526250 |
140 | EGFR | 0.26344655 |
141 | PBK | 0.25629325 |
142 | EPHA2 | 0.24610059 |
143 | PKN1 | 0.24520693 |
144 | CAMK4 | 0.22107415 |
145 | ITK | 0.21346699 |
146 | EPHA4 | 0.20517473 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41442905 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57777869 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40085027 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19341220 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95155731 |
6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74351855 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68823022 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63211121 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61537380 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55054927 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.48243536 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44349188 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29565413 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23273734 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12513641 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.09627482 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98047461 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94165675 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89335130 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87123792 |
21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86253610 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85879033 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83717583 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76525157 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75387423 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71814883 |
27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67434086 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67373233 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66740991 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64172544 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63276800 |
32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60065090 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.54317723 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50411877 |
35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47562572 |
36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42279585 |
37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41654181 |
38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40494695 |
39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38693406 |
40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38136461 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36442952 |
42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.33216840 |
43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32182058 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.28393683 |
45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27544230 |
46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21021928 |
47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14035486 |
48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13485626 |
49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12343202 |
50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02374141 |
51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99862404 |
52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98689620 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97503960 |
54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94469101 |
55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92225451 |
56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90737589 |
57 | Lysine degradation_Homo sapiens_hsa00310 | 0.87993080 |
58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83686650 |
59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83472689 |
60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72983593 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71633277 |
62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70992242 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67847575 |
64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58005150 |
65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56187958 |
66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54459926 |
67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50745295 |
68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46098130 |
69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37517930 |
70 | Prion diseases_Homo sapiens_hsa05020 | 0.34791977 |
71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33543596 |
72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30677501 |
73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30667926 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27339582 |
75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26443906 |
76 | Insulin resistance_Homo sapiens_hsa04931 | 0.24351442 |
77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23078692 |
78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21194930 |
79 | Pertussis_Homo sapiens_hsa05133 | 0.19786593 |
80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17200954 |
81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16799400 |
82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14180390 |
83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.12848023 |
84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03845756 |
85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.03787703 |
86 | Insulin secretion_Homo sapiens_hsa04911 | 0.02906653 |
87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02536091 |
88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02405166 |
89 | Bladder cancer_Homo sapiens_hsa05219 | -0.2271855 |
90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2084294 |
91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2006814 |
92 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1822009 |
93 | Mineral absorption_Homo sapiens_hsa04978 | -0.1753343 |
94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1752470 |
95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1726913 |
96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1700063 |
97 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1540374 |
98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1391653 |
99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1391520 |
100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1034007 |
101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0963389 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0850939 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0848660 |
104 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0804437 |
105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0755062 |
106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0745089 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0543414 |
108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0537612 |
109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0490629 |
110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0245343 |
111 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0190223 |